T

TRiCares

Biotech & Life Sciences · Aschheim, Germany · Founded 2013

TRiCares is a medical device startup, founded in 2013, that operates in the rapidly growing transcatheter heart valve replacement market. The company's primary focus is on the development of a catheter-based tricuspid valve replacement system. This system is designed to help patients suffering from Tricuspid Regurgitation (TR), a serious heart complication where the tricuspid valve does not close properly, causing blood to flow back into the right atrium. This condition affects over 12.7 million patients in Europe alone. TRiCares' innovative solution aims to treat TR without the need for open-heart surgery, offering a less invasive alternative to traditional surgical methods. This is particularly significant given the high-risk nature of open-heart surgeries and the potential for a faster recovery time with minimally invasive procedures. The company's business model revolves around the development, production, and sale of these catheter-based systems to healthcare providers. By offering a unique and effective solution to a widespread health issue, TRiCares is well-positioned to capture a significant share of the heart valve replacement market. The company is headquartered in Paris, France, with an additional office in Munich, Germany, serving a broad European market. TRiCares' potential for growth is substantial, given the high prevalence of heart valve disease and the increasing demand for minimally invasive treatment options. Keywords: Medical Device Startup, Tricuspid Regurgitation, Catheter-Based System, Heart Valve Replacement, Minimally Invasive, Healthcare Providers, European Market, Heart Valve Disease, Innovative Solution, Market Growth.